While we found no evidence for an association to cancer, there are different studies that support our observation of FGFR4 in T2D-related pathways including hepatic glucose, bile, and lipid metabolism, and possibly insulin signaling in a diet-dependent manner (37–40). This evidence concerns the gene FGFR4 and type 2 diabetes mellitus.